Effectiveness of Universal Exercise Unit Exercise on Upper Limb Strength Using Biodex Isokinetic (UEU/CP)

November 14, 2025 updated by: Samaa Hussein Rajab, Cairo University

ROLE OF DESIGNED PROGRAM IN UNIVERSAL EXERCISE UNIT ON UPPER LIMB IN CHILDREN WITH SPASTIC HEMIPLEGIA

The aim of the study is to determine the role of designed program in the universal exercise unit on upper limb function and strength in children with spastic hemiplegia. forty children with spastic hemiplegia cerebral palsy from both sexes had been selected from the Outpatient Clinic of the Faculty of Physical Therapy, Cairo University . Children were divided into two groups of equal numbers; 20 patients in each group. Group A: Children in this group received a selected physical therapy program. Group B: Children in this group received a designed physical therapy program in UEU in addition to the selected physical therapy program. A-Materials for evaluation 1- For the Quality Of Upper Extremity Skill Test (QUEST),2- Biodex Isokinetic systems.Evaluation was carried out for each child individually before and after 3 months of treatment

Study Overview

Detailed Description

This study is designed to answer the following question:

Is there an effect of designed program in universal exercise unit on upper limb function and strength in children with spastic hemiplegia? Purpose of The Study The purpose of the study is to determine the role of designed program in the universal exercise unit on upper limb function and strength in children with spastic hemiplegia.

Null Hypothesis Is there is no role of designed program in the universal exercise unit on the upper limb in children with spastic hemiplegia.

The study was concluded forty children with spastic hemiplegic cerebral palsy from both sexes had been selected from according to the following criteria:

  • children ages were ranged from 5-9 years old.
  • The children had spasticity grades 1, 1+ degree according to Modified Ashworth scale
  • The children were selected to be in level I and II GMFCs
  • The children were selected to be in level II MACs participants had been excluded if they had the following:

    1. Visual or hearing impairment
    2. Orthopedic surgery of upper limbs for the last 6 months
    3. Cardiopulmonary diseases Children were equally assigned into two groups using simple randomization, control group (A) and study group (B). Each group would consist of 20 children with spastic hemiplegia CP.

Group (A): Children in this group received a selected physical therapy program. Group (B): Children in this group received the selected physical therapy program in addition to a designed physical therapy program in UEU.

Evaluation was carried out for each child individually before and after 3 months of treatment.

A-For Assessment

  1. The Quality of Upper Extremity Skill Test (Quest) The QUEST test included 34 items in four domains of (dissociated movement, grasp, weight bearing and protective extension).

    Each child was instructed to hold the position for at least two seconds. The total testing timing including the administration and scoring was approximately 45 minutes.

    The scoring was performed and recorded in scoring box. Even if the item was not tested (I.e: yes, no, not tested)

  2. The Biodex Isokinetic system The testing session had been started with a warm up procedure, consisting of shoulder movements in all directions, push up-exercises against the wall and stretching. For the testing procedure, the closed chain attachment was fixed to the isokinetic dynamometer in a horizontal position. Essentially, this device converts rotational motion at the dynamometer into linear motion, allowing closed kinematic chain or linear movements The evaluation was carried out for each child individually before and after three month of treatment.

Tested muscles were elbow flexors, elbow extensor, shoulder flexors, shoulder extensors.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt, 11432
        • Outpatient Clinic of the Faculty of Physical Therapy, Cairo University's

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Their ages were ranged from 5-9 years old.
  • They had spasticity grades 1, 1+ degree according to Modified Ashworth scale
  • They were selected to be in level I and II GMFCs They were selected to be in level II MACs

Exclusion Criteria:

  • Visual or hearing impairment
  • Orthopedic surgery of upper limbs for the last 6 months
  • Cardiopulmonary diseases

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: control (standard treatment)
children in control group received standard physiotherapy
traditional physio therapy program.
Experimental: experimental
a designed physical therapy program in Universal exercise that began with testing one repetition maximum (1-RM). One repetition maximum (1-RM) was determined through the chest press. children had been targeted upper limb strengthening program

designed physical therapy program in Universal exercise unit for strengthening upper limb. fundamental beginning position for every exercise. Total session time in the UEU was approximately 30 minutes.

The resisted exercise targeted shoulder flexor and extensor muscles, shoulder abductor and adductor muscles and for elbow extensor muscles

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Quality of Upper Extremity Skill Test
Time Frame: The total testing timing including the administration and scoring was approximately 45 minutes. The scoring was performed and recorded in scoring box. Even if the item was not tested (I.e: yes, no, not tested)
The Quality of Upper Extremity Skill est test included 34 items in four domains of dissociated movement, grasp, weight bearing and protective extension. All children in this study were assessed in the four domains. The total number of 'yes' and 'no' responses provide the raw score for each domain. This is then weighted and transformed into a final score range of zero to 100.
The total testing timing including the administration and scoring was approximately 45 minutes. The scoring was performed and recorded in scoring box. Even if the item was not tested (I.e: yes, no, not tested)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Biodex Isokinetic system
Time Frame: The evaluation was carried out for each child individually before and after three month of treatment.
The testing session had been started with a warm up procedure, consisting of shoulder movements in all directions, push up-exercises against the wall and stretching Tested muscles were elbow flexors, elbow extensor, shoulder abductors, shoulder adductors
The evaluation was carried out for each child individually before and after three month of treatment.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Naglaa A Zaky, professor, Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 10, 2024

Primary Completion (Actual)

April 20, 2025

Study Completion (Actual)

September 1, 2025

Study Registration Dates

First Submitted

November 14, 2025

First Submitted That Met QC Criteria

November 14, 2025

First Posted (Actual)

November 18, 2025

Study Record Updates

Last Update Posted (Actual)

November 18, 2025

Last Update Submitted That Met QC Criteria

November 14, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • P.T.REC/012/004849

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebral Palsy Spastic Hemiplegic

Clinical Trials on Control (Standard treatment)

Subscribe